Unknown

Dataset Information

0

PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma.


ABSTRACT:

Background

Pazopanib, a multitargeted tyrosine kinase inhibitor, is recommended as the standard treatment for refractory soft tissue sarcoma (STS). However, there are comparatively few molecular determinants for predicting pazopanib efficacy. Based on correlative studies regarding the predictive impact of PD-L1, we investigated the clinical relevance of PD-L1 expression and evaluated its value for predicting pazopanib efficacy.

Methods

Tumour tissues from patients with advanced STS who went on to receive pazopanib were assessed for PD-L1 expression. Immunohistochemistry was performed using an anti-PD-L1 antibody, and the PD-L1 tumour proportion score (TPS) was calculated as the percentage of at least 100 viable cells with positive expression, defined as TPS ≥ 1%.

Results

Among the 67 patients, 8 (11.9%) achieved partial response and a median progression-free survival (PFS) of 4.8 months (95% CI 3.8-5.7). PD-L1 expression in tumour cells was detected in 13 (19.4%) cases and the TPS scores ranged from 1 to 100%, as follows: 0 (n = 54, 80.6%), 1-9% (n = 3, 4.5%), 10-49% (n = 9, 13.4%), and ≥ 50% (n = 1, 1.5%). PD-L1 positive tumours exhibited a poorer response to pazopanib treatment than the PD-L1 negative tumours (0% vs 14.8%, P = 0.07). PD-L1-positive tumours had significantly shorter PFS than the PD-L1-negative tumours (median PFS 2.8 vs 5.1 months, P = 0.003), and PD-L1 positivity was an independent predictor of poor response to pazopanib treatment (HR 2.77, 95% CI; 1.45-5.56, P = 0.006).

Conclusion

We identified that PD-L1 expression can help predict the clinical outcome of patients with advanced STS treated with pazopanib. Based on our study, stratification should be actively considered in order to identify patients who will benefit from pazopanib or further therapeutic strategies for future clinical trials.

SUBMITTER: Kim SK 

PROVIDER: S-EPMC8011221 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4938996 | biostudies-literature
| S-EPMC5505649 | biostudies-literature
| S-EPMC10101793 | biostudies-literature
| S-EPMC3604972 | biostudies-literature
| S-EPMC4257119 | biostudies-literature
| S-EPMC5559963 | biostudies-other
| S-EPMC5384369 | biostudies-literature
| S-EPMC7991270 | biostudies-literature
| S-EPMC5828212 | biostudies-literature
| S-EPMC4082932 | biostudies-literature